WIGRAINE TAB .1 MG
BELLADONNA : .1 MG CAFFEINE : 100 MG ERGOTAMINE TARTRATE : 1 MG · DIN 00489220 · ORGANON CANADA LTD LTEE
Health Canada status: CANCELLED POST MARKET
What is WIGRAINE TAB?
WIGRAINE TAB .1 MG contains BELLADONNA : .1 MG CAFFEINE : 100 MG ERGOTAMINE TARTRATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00489220, held by ORGANON CANADA LTD LTEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00489220 |
|---|---|
| Brand name | WIGRAINE TAB |
| Generic / active ingredient | BELLADONNA : .1 MG CAFFEINE : 100 MG ERGOTAMINE TARTRATE : 1 MG |
| Manufacturer | ORGANON CANADA LTD LTEE |
| Strength | .1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N02CA52 ERGOTAMINE, COMBINATIONS EXCL. PSYCHOLEPTICS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Aug-1999 |
What can be used instead?
Other Canadian products sharing ATC code N02CA52 ERGOTAMINE, COMBINATIONS EXCL. PSYCHOLEPTICS. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CAFERGOT SUP | 100 MG | SUPPOSITORY | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00782920 |
| CAFERGOT TAB | 100 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00176095 |
| ERGODRYL CAP | 25 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00156086 |
| MEGRAL TABS | 100 MG | TABLET | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068586 |
| WIGRAINE SUPPOSITORIES | 1 MG | SUPPOSITORY | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | DIN 00489212 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.